Publications by authors named "Barbara Ruozi"

Claim this Profile
C
Corrigendum to 'Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease' J Control Release. 2021 Feb 10;330:587-598.
Giulia Birolini, Marta Valenza, Ilaria Ottonelli, Alice Passoni, Monica Favagrossa, Barbara Ruozi

J Control Release· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug delivery systems for mitochondrial targeting.
Sofia Tagliavini, Mara Filippini, Alessandro Anderlini, Riccardo Caraffi, Cecilia Baraldi, Barbara Ruozi

Nanoscale· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipidic nanomedicines enhance Hinokitiol activity on human primary macrophages from Ferroportin disease patients.
Alessandro Anderlini, Manuela Sabelli, Elena Corradini, Sofia Tagliavini, Cecilia Baraldi, Barbara Ruozi

Int J Pharm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease" [Pharmacol. Res. 194 (2023) 106823].
Giulia Birolini, Marta Valenza, Ilaria Ottonelli, Francesca Talpo, Lucia Minoli, Barbara Ruozi

Pharmacol Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LAT Gel: from the Galenical Laboratory to the Paediatric Emergency Room - A Fondazione Policlinico Gemelli IRCCS Experience.
Michele Favia, Elena Lupi, Michela Sperandeo, Lidia Di Cerbo, Antonella Sabia, Barbara Ruozi

Hosp Pharm· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advantages and challenges of polymer-lipid hybrid nanoparticles for the delivery of biotech drugs.
Ilaria Ottonelli, Cecilia Baraldi, Barbara Ruozi, Maria Angela Vandelli, Giovanni Tosi

Nanomedicine (Lond)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging the gap between toxicity and carcinogenicity of mineral fibres by connecting the fibre parameters to the key characteristics of carcinogens: A comprehensive model inspiring asbestos-induced cancer prevention strategies.
Alessandro F Gualtieri, Erika Ferrari, Luca Rigamonti, Barbara Ruozi, Serena Mirata

Curr Res Toxicol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges of enzyme therapy: Why two players are better than one.
Sabrina Cuoghi, Riccardo Caraffi, Alessandro Anderlini, Cecilia Baraldi, Elena Enzo, Barbara Ruozi

Wiley Interdiscip Rev Nanomed Nanobiotechnol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology.
Ilaria Ottonelli, Elisa Adani, Andrea Bighinati, Sabrina Cuoghi, Giovanni Tosi, Barbara Ruozi

Int J Nanomedicine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells.
Arianna Rinaldi, Florence Dumas, Jason Thomas Duskey, Carol Imbriano, Silvia Belluti, Barbara Ruozi

Int J Pharm· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Quantitative comparison of the protein corona of nanoparticles with different matrices" [Int J Pharm X 2022 Oct 21;4: 100136].
Ilaria Ottonelli, Jason Thomas Duskey, Filippo Genovese, Francesca Pederzoli, Riccardo Caraffi, Barbara Ruozi

Int J Pharm X· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease.
Giulia Birolini, Marta Valenza, Ilaria Ottonelli, Francesca Talpo, Lucia Minoli, Barbara Ruozi

Pharmacol Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor.
Ilaria Ottonelli, Aruna Sharma, Barbara Ruozi, Giovanni Tosi, Jason Thomas Duskey

Adv Neurobiol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury.
Marzia Moretti, Riccardo Caraffi, Luca Lorenzini, Ilaria Ottonelli, Michele Sannia, Barbara Ruozi

Cells· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization.
Francesca Rodà, Riccardo Caraffi, Silvia Picciolini, Giovanni Tosi, Maria Angela Vandelli, Barbara Ruozi

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative comparison of the protein corona of nanoparticles with different matrices.
Ilaria Ottonelli, Jason Thomas Duskey, Filippo Genovese, Francesca Pederzoli, Riccardo Caraffi, Barbara Ruozi

Int J Pharm X· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles.
Ilaria Ottonelli, Andrea Bighinati, Elisa Adani, François Loll, Riccardo Caraffi, Barbara Ruozi

Pharmaceutics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model.
Alessia Romeo, Angela Bonaccorso, Claudia Carbone, Gabriella Lupo, Carmelina Daniela Anfuso, Barbara Ruozi

Int J Pharm· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts.
Rebecca Voltan, Paola Secchiero, Barbara Ruozi, Flavio Forni, Chiara Agostinis

Clin Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments.
Jason Thomas Duskey, Arianna Rinaldi, Ilaria Ottonelli, Riccardo Caraffi, Chiara Alessia De Benedictis, Barbara Ruozi

Pharmaceutics· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines.
Arianna Rinaldi, Riccardo Caraffi, Maria Vittoria Grazioli, Natalia Oddone, Luciana Giardino, Barbara Ruozi

Polymers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tunneling Nanotubes: A New Target for Nanomedicine?
Ilaria Ottonelli, Riccardo Caraffi, Giovanni Tosi, Maria Angela Vandelli, Jason Thomas Duskey, Barbara Ruozi

Int J Mol Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tween Preserves Enzyme Activity and Stability in PLGA Nanoparticles.
Jason Thomas Duskey, Ilaria Ottonelli, Arianna Rinaldi, Irene Parmeggiani, Barbara Zambelli, Barbara Ruozi

Nanomaterials (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microfluidic Technology for the Production of Hybrid Nanomedicines.
Ilaria Ottonelli, Jason Thomas Duskey, Arianna Rinaldi, Maria Vittoria Grazioli, Irene Parmeggiani, Barbara Ruozi

Pharmaceutics· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations.
Antonella Iudicello, Filippo Genovese, Valentina Strusi, Massimo Dominici, Barbara Ruozi

Pharmaceuticals (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis